Cargando…
P-143: Breakthrough – a designated pharmacist in the hemato-oncology department improves both quality and sequence of drug treatment and reduces ADR in Multiple Myeloma patients during Covid-19 pandemic
BACKGROUND: In March 2020, COVID19 break out and since then the world has been facing a new reality. Multiple Myeloma patients due to their disease and chemotherapy were considered as a high-risk group for infection. Since then, in an attempt to avoid multiple exposures, encounters between patients...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8580187/ http://dx.doi.org/10.1016/S2152-2650(21)02270-9 |